x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies

Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:

Read Now
4 min. read
Read more
 
Blog

Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

Dr. Gelinas answers audience questions we weren’t able to address during the webinar.

Read Now
6 min. read
Read more
 
Blog

Protocol Feasibility to Promote Trial Efficiency

Many studies do not accrue subjects at the site level, which contributes to a significant amount of waste of staff time and monetary resources. Read more:

Read Now
8 min. read
Read more
 
Blog

Study Activation: A Complex Process That Doesn’t Have to Be Painful

If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.

Read Now
3 min. read
Read more
 
Blog

How Research Informs the COVID-19 Response

Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more:

Read Now
5 min. read
Read more
 
Blog

IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider

Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:

Read Now
5 min. read
Read more
 
Blog

Are “Virtual Trials” Mainstream Yet?

Advarra VP of Insitutional Services James Riddle discusses using virtual trial components in traditional study designs. Read more:

Read Now
5 min. read
Read more
 
White Paper

Informed Consent: 6 Approaches to Increase Participant Comprehension

Explore six approaches for improving informed consent and supporting participants’ understanding of the studies they are asked to join.

Read Now
Read more
 
Blog

Key Biosafety Considerations for Coronavirus Research

Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:

Read Now
7 min. read
Read more
 
Blog

Revised Common Rule Compliance Now in Full Effect—and What That Means

The Revised Common Rule is here after multiple delays, exceptions, and many training sessions. As of January 20, 2020, this regulation is in full effect.

Read Now
3 min. read
Read more
 
Blog

Beyond the Regulations: More Considerations for Emergency Research

Go beyond the regulatory requirements and examine three key actions research organizations must consider before conducting planned emergency research.

Read Now
7 min. read
Read more
 
Blog

Most Popular Blogs of 2019

What did the research community enjoy most in 2019? Read Advarra's most popular blogs from industry experts and IRB members here.

Read Now
2 min. read
Read more